UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Malignant glioma subset from Actuate 1801: A phase 1/2 study of 9-ING-41, a glycogen synthase kinase 3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory hematologic malignancies or solid tumors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2051-2051

2021

Volltextzugriff (PDF)

Perioperative DD-MVAC as a safe and efficacious treatment for MIBC: Results of a retrospective community center study with clinical correlates of toxicity and response

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15540-e15540

2015

Volltextzugriff (PDF)

A phase 1 study of TPST-1120 as a single agent and in combination with nivolumab in subjects with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3005-3005

2022

Volltextzugriff (PDF)

SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer with overall survival follow up

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.536-536

2022

Volltextzugriff (PDF)

Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3507-3507

2020

Volltextzugriff (PDF)

Correlates of overall survival (OS) in metastatic uveal melanoma (mUM) and a randomized trial of cabozantinib (cabo) versus chemotherapy (chemo)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9506-9506

2019

Volltextzugriff (PDF)

Nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy (chemo) in first-line metastatic non-small cell lung cancer (NSCLC): CheckMate 568 Part 2

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9560-9560

2020

Volltextzugriff (PDF)

Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3058-3058

2020

Volltextzugriff (PDF)

Clinical implications of repeat tumor biopsy (RTB) in patients (pts) with advanced lung cancer (LC): The Cleveland Clinic (CC) experience

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.8077-8077

2015

Volltextzugriff (PDF)

SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4506-4506

2019

Volltextzugriff (PDF)

Randomized phase II study comparing the MET inhibitor cabozantinib to temozolomide (TMZ) or dacarbazine (DTIC) in ocular melanoma: A091201

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS9087-TPS9087

2015

Volltextzugriff (PDF)

Impact of a Stage IV NSCLC care pathway on front-line (FL) and maintenance (M) chemotherapy use at the Cleveland Clinic Taussig Cancer Institute (TCI)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.6609-6609

2015

Volltextzugriff (PDF)

Serum and tumor biomarkers to predict outcome in the eLung trial, a multicenter, randomized phase IIb study of standard platinum doublets (PD) plus cetuximab (CET) as first-line treatment of advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8044-8044

2013

Volltextzugriff (PDF)

Rising Incidence of Sporothrix brasiliensis Infections, Curitiba, Brazil, 2011-2022

Emerging infectious diseases, 2023-07, Vol.29 (7), p.1330-1339

2023

Volltextzugriff (PDF)

Should the Vancomycin Minimal Inhibitory Concentration be used as an Infant Critical Care Regular Criteria?

Current pharmaceutical biotechnology, 2020-01, Vol.21 (11), p.1052-1058

2020

Volltextzugriff (PDF)

Episodic generalized involuntary muscle contractions and weakness in a 2-year-old castrated male Chihuahua

Journal of the American Veterinary Medical Association, 2023-08, Vol.261 (8), p.1231-3

2023

Volltextzugriff (PDF)

Methodologies to determine the ripening stage of coffee fruits

Australian journal of crop science, 2023-11 (17(11):2023), p.841-846

2023

Volltextzugriff (PDF)

Effect of coal fly ash treatments on synthesis of high-quality zeolite A as a potential additive for warm mix asphalt

Materials chemistry and physics, 2022-01, Vol.275, p.125197, Article 125197

2022

Volltextzugriff (PDF)

Vancomycin Therapeutic Regime Adjustment in Newborns and Infants with Bacterial Infection: Case Series

Current pharmaceutical biotechnology, 2019-01, Vol.20 (4), p.346-351

2019

Volltextzugriff (PDF)

Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model

Nutrients, 2021-08, Vol.13 (9), p.2981

2021

Volltextzugriff (PDF)

Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease

Gastrointestinal endoscopy, 2017-08, Vol.86 (2), p.299-306

2017

Volltextzugriff (PDF)

Improving the ability of Bulk Built-In Current Sensors to detect Single Event Effects by using triple-well CMOS

Microelectronics and reliability, 2014-09, Vol.54 (9-10), p.2289-2294

2014

Volltextzugriff (PDF)

Critical review of multisensory integration programs and proposal of a theoretical framework for its combination with neurocognitive training

Expert review of neurotherapeutics, 2022-07, Vol.22 (7), p.557-566

2022

Volltextzugriff (PDF)

26 – 50 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(34)
Humans
(19)
Technology
(11)
Oncology
(9)
Engineering Sciences
(8)
Female
(8)
Male
(8)
Micro And Nanotechnologies
(8)
Microelectronics
(8)
Adult
(7)
Computer Science
(7)
Engineering
(7)
Engineering, Electrical & Electronic
(7)
Neurosciences & Neurology
(7)
Aged
(6)
Pharmacology & Pharmacy
(6)
Physical Sciences
(6)
Biological And Medical Sciences
(5)
Brazil
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Malignant glioma subset from Actuate 1801: A phase 1/2 study of 9-ING-41, a glycogen synthase kinase 3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory hematologic malignancies or solid tumors

Perioperative DD-MVAC as a safe and efficacious treatment for MIBC: Results of a retrospective community center study with clinical correlates of toxicity and response

A phase 1 study of TPST-1120 as a single agent and in combination with nivolumab in subjects with advanced solid tumors

SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer with overall survival follow up

Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors

Correlates of overall survival (OS) in metastatic uveal melanoma (mUM) and a randomized trial of cabozantinib (cabo) versus chemotherapy (chemo)

Nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy (chemo) in first-line metastatic non-small cell lung cancer (NSCLC): CheckMate 568 Part 2

Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results

Clinical implications of repeat tumor biopsy (RTB) in patients (pts) with advanced lung cancer (LC): The Cleveland Clinic (CC) experience

SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer

Randomized phase II study comparing the MET inhibitor cabozantinib to temozolomide (TMZ) or dacarbazine (DTIC) in ocular melanoma: A091201

Impact of a Stage IV NSCLC care pathway on front-line (FL) and maintenance (M) chemotherapy use at the Cleveland Clinic Taussig Cancer Institute (TCI)

Serum and tumor biomarkers to predict outcome in the eLung trial, a multicenter, randomized phase IIb study of standard platinum doublets (PD) plus cetuximab (CET) as first-line treatment of advanced non-small cell lung cancer (NSCLC)

Rising Incidence of Sporothrix brasiliensis Infections, Curitiba, Brazil, 2011-2022

Should the Vancomycin Minimal Inhibitory Concentration be used as an Infant Critical Care Regular Criteria?

Episodic generalized involuntary muscle contractions and weakness in a 2-year-old castrated male Chihuahua

Methodologies to determine the ripening stage of coffee fruits

Effect of coal fly ash treatments on synthesis of high-quality zeolite A as a potential additive for warm mix asphalt

Karyotypes of Manatees: New Insights into Hybrid Formation (Trichechus inunguis × Trichechus m. manatus) in the Amazon Estuary

Vancomycin Therapeutic Regime Adjustment in Newborns and Infants with Bacterial Infection: Case Series

Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model

Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease

Improving the ability of Bulk Built-In Current Sensors to detect Single Event Effects by using triple-well CMOS

Crack cocaine inhalation increases seizure susceptibility by reducing acetylcholinesterase activity

Critical review of multisensory integration programs and proposal of a theoretical framework for its combination with neurocognitive training

Suchergebnisse filtern